S1P Therapeutics

Our mission is to develop drugs targeting novel nodes in the S1P pathway

S1P Therapeutics is a preclinical-stage biotechnology company focused on developing drugs for the treatment of kidney and autoimmune diseases. Our strategy will realize medicines that are effective with less toxicity than existing S1P pathway drugs.

S1P Therapeutics is led by drug hunters and industry leaders with decades of experience in discovery, development, and pharmaceutical startups.